BOURGEON CAPITAL MANAGEMENT LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
BOURGEON CAPITAL MANAGEMENT LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$371
-55.5%
1750.0%0.00%
Q2 2023$833
-16.5%
1750.0%0.00%
Q1 2023$998
-43.5%
1750.0%0.00%
Q4 2022$1,766
-55.8%
1750.0%0.00%
-100.0%
Q3 2022$4,0000.0%1750.0%0.00%0.0%
Q2 2022$4,000
-42.9%
1750.0%0.00%
-50.0%
Q1 2022$7,000
-30.0%
1750.0%0.00%0.0%
Q4 2021$10,0000.0%1750.0%0.00%0.0%
Q3 2021$10,000
-33.3%
1750.0%0.00%
-33.3%
Q2 2021$15,000
+7.1%
1750.0%0.00%0.0%
Q1 2021$14,000
-12.5%
1750.0%0.00%
-25.0%
Q4 2020$16,000
+128.6%
1750.0%0.00%
+100.0%
Q3 2020$7,000
+16.7%
1750.0%0.00%0.0%
Q2 2020$6,000
+50.0%
1750.0%0.00%0.0%
Q1 2020$4,000
+33.3%
1750.0%0.00%
+100.0%
Q4 2019$3,000
-81.2%
175
-82.5%
0.00%
-88.9%
Q3 2019$16,000
-83.5%
1,000
-93.5%
0.01%
-83.0%
Q2 2014$97,00015,3840.05%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders